Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Helmatac
2. Methyl 5-butyl-2-benzimidazolecarbamate
3. Parbendazole, 2-(14)c-labeled Cpd Di-hcl
4. Skf 29044
5. Skf-29044
1. 14255-87-9
2. Helmatac
3. Methyl (5-butyl-1h-benzo[d]imidazol-2-yl)carbamate
4. Worm Guard
5. Verminum
6. Skf 29044
7. Helatac
8. Pbdz
9. Sk&f 29044
10. Methyl 5-butyl-2-benzimidazolecarbamate
11. Tcmdc-131798
12. Carbamic Acid, (5-butyl-1h-benzimidazol-2-yl)-, Methyl Ester
13. Methyl N-(6-butyl-1h-benzimidazol-2-yl)carbamate
14. Parbendazole Free Base
15. 5-butyl-2-(carbomethoxyamino)benzimidazole
16. N4x8wvx2ug
17. 5-butyl-2-benzimidazolecarbamic Acid Methyl Ester
18. Nsc-256420
19. 14255-87-9 (free Base)
20. Ncgc00016706-01
21. Parbendazol
22. Cas-14255-87-9
23. Methyl (5-butyl-1h-benzimidazol-2-yl)carbamate
24. Dsstox_cid_25410
25. Dsstox_rid_80861
26. Dsstox_gsid_45410
27. Methyl 5-butyl-1h-benzo[d]imidazol-2-ylcarbamate
28. Methyl ~{n}-(5-butyl-1~{h}-benzimidazol-2-yl)carbamate
29. Parbendazolum
30. N-(6-butyl-1h-benzimidazol-2-yl)carbamic Acid Methyl Ester
31. Parbendazol [inn-spanish]
32. Parbendazolum [inn-latin]
33. Einecs 238-133-3
34. Unii-n4x8wvx2ug
35. Skf-29044
36. Parbendazole [usan:inn:ban]
37. 2-benzimidazolecarbamic Acid, 5-butyl-, Methyl Ester
38. (4-butyl-1h-benzimidazol-2-yl)-carbamic Acid Methyl Ester
39. N-(butyl-5, Benzimidazolyl)-2, Carbamate De Methyle [french]
40. Methyl 5(6)-butyl-2-benzimidazolecarbamate
41. Prestwick0_001110
42. Prestwick1_001110
43. Prestwick2_001110
44. Prestwick3_001110
45. Parbendazole [mi]
46. Parbendazole (usan/inn)
47. Parbendazole [inn]
48. Parbendazole [usan]
49. Bspbio_001220
50. Parbendazole [usp-rs]
51. Schembl259455
52. Spbio_003090
53. Bpbio1_001342
54. Chembl528271
55. N-(butyl-5, Benzimidazolyl)-2, Carbamate De Methyle
56. Dtxsid0045410
57. Chebi:94267
58. Hms1571m22
59. Hms2098m22
60. Hms3715m22
61. Amy13606
62. Zinc5424253
63. Tox21_110571
64. Mfcd00864534
65. Nsc256420
66. S2444
67. Wln: T56 Bm Dnj Cmvo1 G4
68. Akos015898352
69. Akos015967508
70. Tox21_110571_1
71. 2h-benzimidazole, Carbamic Acid Deriv.
72. Ac-1936
73. Ccg-221110
74. Nsc 256420
75. Sk&f-29044
76. Methyl 5-butylbenzimidazole-2-carbamate
77. Ncgc00016706-02
78. Ncgc00016706-03
79. Ncgc00016706-04
80. Ncgc00016706-05
81. Ncgc00016706-07
82. As-68370
83. 2-carbomethoxyamino-5-n-butylbenzimidazole
84. Hy-115364
85. Ab00514054
86. Cs-0035171
87. Ft-0630413
88. Methyl 5-butyl-1h-benzimidazol-2-ylcarbamate
89. D05365
90. F18423
91. Parbendazole, Vetranal(tm), Analytical Standard
92. 255p879
93. A885179
94. Methyl N-(5-butyl-1h-benzimidazol-2-yl)carbamate
95. Sr-01000872691
96. (5-butyl-2-benzimidazole)carbamic Acid Methyl Ester
97. Methyl (6-butyl-1h-benzo[d]imidazol-2-yl)carbamate
98. Sr-01000872691-1
99. 4-(tert-butoxycarbonyl)thiomorpholine-3-carboxylicacid
100. Brd-k02407574-001-03-0
101. Brd-k02407574-001-04-8
102. Brd-k02407574-001-06-3
103. Q27166068
104. Methyl N-(5-butyl-1h-1,3-benzodiazol-2-yl)carbamate
105. Parbendazole, United States Pharmacopeia (usp) Reference Standard
106. Carbamic Acid, N-(6-butyl-1h-benzimidazol-2-yl)-, Methyl Ester
107. H1c
| Molecular Weight | 247.29 g/mol |
|---|---|
| Molecular Formula | C13H17N3O2 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 5 |
| Exact Mass | 247.132076794 g/mol |
| Monoisotopic Mass | 247.132076794 g/mol |
| Topological Polar Surface Area | 67 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 285 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Parbendazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Parbendazole, including repackagers and relabelers. The FDA regulates Parbendazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Parbendazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Parbendazole supplier is an individual or a company that provides Parbendazole active pharmaceutical ingredient (API) or Parbendazole finished formulations upon request. The Parbendazole suppliers may include Parbendazole API manufacturers, exporters, distributors and traders.
Parbendazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Parbendazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Parbendazole GMP manufacturer or Parbendazole GMP API supplier for your needs.
A Parbendazole CoA (Certificate of Analysis) is a formal document that attests to Parbendazole's compliance with Parbendazole specifications and serves as a tool for batch-level quality control.
Parbendazole CoA mostly includes findings from lab analyses of a specific batch. For each Parbendazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Parbendazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Parbendazole EP), Parbendazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Parbendazole USP).
LOOKING FOR A SUPPLIER?
